合理用药
不良反应
新药前沿
药物治疗
关键字:
搜索栏目:
 首页 >> 合理用药 >> 药物治疗
高hsCRP可预测高血压前期人群缺血性卒中风险
作者:本站 时间:2010-11-11 点击:620 来源:Am J Hypertens
<SPAN style="FONT-SIZE: 9pt; COLOR: #3e3e3e; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">&nbsp;&nbsp;&nbsp; 日本一项研究纳入</SPAN><SPAN lang=EN-US style="FONT-SIZE: 9pt; COLOR: #3e3e3e; FONT-FAMILY: Arial; mso-fareast-font-family: 宋体; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">22676</SPAN><SPAN style="FONT-SIZE: 9pt; COLOR: #3e3e3e; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">名既往无心血管病史、基线接受血浆高敏</SPAN><SPAN lang=EN-US style="FONT-SIZE: 9pt; COLOR: #3e3e3e; FONT-FAMILY: Arial; mso-fareast-font-family: 宋体; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">C</SPAN><SPAN style="FONT-SIZE: 9pt; COLOR: #3e3e3e; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">反应蛋白(</SPAN><SPAN lang=EN-US style="FONT-SIZE: 9pt; COLOR: #3e3e3e; FONT-FAMILY: Arial; mso-fareast-font-family: 宋体; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">hsCRP</SPAN><SPAN style="FONT-SIZE: 9pt; COLOR: #3e3e3e; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">)检测的受试者,平均随访</SPAN><SPAN lang=EN-US style="FONT-SIZE: 9pt; COLOR: #3e3e3e; FONT-FAMILY: Arial; mso-fareast-font-family: 宋体; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">2.7</SPAN><SPAN style="FONT-SIZE: 9pt; COLOR: #3e3e3e; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">年结果显示,对于处于高血压前期的人群,</SPAN><SPAN lang=EN-US style="FONT-SIZE: 9pt; COLOR: #3e3e3e; FONT-FAMILY: Arial; mso-fareast-font-family: 宋体; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">hsCRP</SPAN><SPAN style="FONT-SIZE: 9pt; COLOR: #3e3e3e; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">可作为标志物预测短期缺血性卒中风险。该研究发表于《美国高血压杂志》</SPAN><SPAN lang=EN-US style="FONT-SIZE: 9pt; COLOR: #3e3e3e; FONT-FAMILY: Arial; mso-fareast-font-family: 宋体; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">[Am J Hypertens 2010</SPAN><SPAN style="FONT-SIZE: 9pt; COLOR: #3e3e3e; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">,</SPAN><SPAN lang=EN-US style="FONT-SIZE: 9pt; COLOR: #3e3e3e; FONT-FAMILY: Arial; mso-fareast-font-family: 宋体; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">23</SPAN><SPAN style="FONT-SIZE: 9pt; COLOR: #3e3e3e; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">(</SPAN><SPAN lang=EN-US style="FONT-SIZE: 9pt; COLOR: #3e3e3e; FONT-FAMILY: Arial; mso-fareast-font-family: 宋体; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">10</SPAN><SPAN style="FONT-SIZE: 9pt; COLOR: #3e3e3e; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">),</SPAN><SPAN lang=EN-US style="FONT-SIZE: 9pt; COLOR: #3e3e3e; FONT-FAMILY: Arial; mso-fareast-font-family: 宋体; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">1108]</SPAN><SPAN style="FONT-SIZE: 9pt; COLOR: #3e3e3e; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">。</SPAN>
返回>>>
浙江省医院药事管理质控中心网 版权所有@2008 All Right Reserved。 浙江省医院药事管理质控中心主办
地址:杭州市庆春路79号(310003)        Email:zhejiangyszk@163.com
建议浏览器IE6.0+ 分辨率:1024*768以上